Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan Paradise

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Food and Drug Law Journal|June 12, 2004
European opposition to exclusive control over predictive breast cancer testing and the inherent implications for U.S. patent law and public policy: a case study of the Myriad Genetics' BRCA patent controversyJordan Paradise
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|December 13, 2023
Mifepristone Paternalism at the FDAJordan Paradise
JAMA|January 13, 2023
The CRISPR Patent Ruling and Implications for MedicineJordan Paradise
Yale Journal of Health Policy, Law, and Ethics|December 18, 2013
No sisyphean task: how the FDA can regulate electronic cigarettesJordan Paradise
Seton Hall Law Review|July 12, 2011
Foreword: Follow-on Biologics: Implementation Challenges and OpportunitiesJordan Paradise
American Journal of Law & Medicine|August 18, 2021
Information Opacity in Biopharmaceutical Innovation Through the Lens of COVID-19Jordan Paradise
American Journal of Law & Medicine|August 15, 2018
21<sup>st</sup> Century Citizen Pharma: The FDA & Patient-Focused Product DevelopmentJordan Paradise
Plos Medicine|June 24, 2005
Call for biohistory guidelinesJordan Paradise
American Journal of Law & Medicine|August 5, 2015
The Legal and Regulatory Status of Biosimilars: How Product Naming and State Substitution Laws May Impact the United States Healthcare SystemJordan Paradise
AMA Journal of Ethics|April 24, 2019
Regulating Nanomedicine at the Food and Drug AdministrationJordan Paradise
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Food and Drug Law Journal|June 12, 2004
European opposition to exclusive control over predictive breast cancer testing and the inherent implications for U.S. patent law and public policy: a case study of the Myriad Genetics' BRCA patent controversyJordan Paradise
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|December 13, 2023
Mifepristone Paternalism at the FDAJordan Paradise
JAMA|January 13, 2023
The CRISPR Patent Ruling and Implications for MedicineJordan Paradise
Yale Journal of Health Policy, Law, and Ethics|December 18, 2013
No sisyphean task: how the FDA can regulate electronic cigarettesJordan Paradise
Seton Hall Law Review|July 12, 2011
Foreword: Follow-on Biologics: Implementation Challenges and OpportunitiesJordan Paradise
American Journal of Law & Medicine|August 18, 2021
Information Opacity in Biopharmaceutical Innovation Through the Lens of COVID-19Jordan Paradise
American Journal of Law & Medicine|August 15, 2018
21<sup>st</sup> Century Citizen Pharma: The FDA & Patient-Focused Product DevelopmentJordan Paradise
Plos Medicine|June 24, 2005
Call for biohistory guidelinesJordan Paradise
American Journal of Law & Medicine|August 5, 2015
The Legal and Regulatory Status of Biosimilars: How Product Naming and State Substitution Laws May Impact the United States Healthcare SystemJordan Paradise
AMA Journal of Ethics|April 24, 2019
Regulating Nanomedicine at the Food and Drug AdministrationJordan Paradise
Pageof 3